PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-20.48%
Both yoy net incomes decline, with MCHP at -19.36%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-2.95%
Negative yoy D&A while MCHP is 34.23%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-95.65%
Negative yoy deferred tax while MCHP stands at 87.71%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
30.00%
SBC growth well above MCHP's 7.32%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-265.34%
Both reduce yoy usage, with MCHP at -104.24%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-169.06%
Both yoy AR lines negative, with MCHP at -105.42%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-81.82%
Negative yoy inventory while MCHP is 106.74%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-460.00%
Both negative yoy AP, with MCHP at -143.13%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-400.00%
Both reduce yoy usage, with MCHP at -66.63%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
96.35%
Well above MCHP's 22.82%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-52.12%
Both yoy CFO lines are negative, with MCHP at -18.47%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
1.60%
Some CapEx rise while MCHP is negative at -33.10%. John Neff would see competitor possibly building capacity while we hold back expansions.
-100.00%
Negative yoy acquisition while MCHP stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
64.25%
Purchases well above MCHP's 55.42%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
29.47%
We have some liquidation growth while MCHP is negative at -12.50%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
103.45%
We have some outflow growth while MCHP is negative at -30.34%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
132.18%
We have mild expansions while MCHP is negative at -396.05%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
We repay more while MCHP is negative at -233837.59%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
75.71%
We slightly raise equity while MCHP is negative at -67.50%. John Neff sees competitor possibly preserving share count or buying back shares.
4.01%
Buyback growth of 4.01% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.